Bipartisan Bill H.R. 7391 Would Exempt FQHCs from 340B Rebate Model
Issue
Reps. Auchincloss (D-MA) and Bergman (R-MI) introduced the Community Health Center Drug Pricing Protection Act to exempt FQHCs from HRSA's 340B Rebate Model Pilot Program.
The bill mandates upfront ceiling-price purchasing — no post-purchase reconciliation. By September 2026 it had 58 cosponsors and no action since its February 5 referral. HRSA's RFI on 340B rebates has comments due April 20, 2026.
FQHCs account for 1% of healthcare spending but treat 10% of Americans.
Key points
- Bipartisan bill H.R. 7391 would exempt FQHCs from HRSA's 340B Rebate Model Pilot Program
- 58 cosponsors by September 2026, still in committee — would mandate upfront ceiling-price purchasing (no post-purchase reconciliation)
- HRSA's RFI on 340B rebates has comments due April 20, 2026
- FQHCs account for 1% of healthcare spending but treat 10% of Americans
- Action: Submit comments on HRSA RFI before April 20 deadline
Sources for this story
U.S. House of RepresentativesSources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
Part of
- 340B drug pricing
HRSA's rebate model pilot · Federal 340B legislation
FQHC Talent. (2026, February 10). Bipartisan Bill H.R. 7391 Would Exempt FQHCs from 340B Rebate Model. Source: U.S. House of Representatives. Retrieved October 6, 2026, from https://www.fqhctalent.com/intel/hr-7391-340b-fqhc-protection-act